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Abstract
Background:  Functional screens based on dsRNA-mediated gene silencing identified several
Anopheles gambiae genes that limit Plasmodium berghei infection. However, some of the genes
identified in these screens have no effect on the human malaria parasite Plasmodium falciparum;
raising the question of whether different mosquito effector genes mediate anti-parasitic responses
to different Plasmodium species.
Results: Four new An. gambiae (G3) genes were identified that, when silenced, have a different
effect on P. berghei (Anka 2.34) and P. falciparum (3D7) infections. Orthologs of these genes, as well
as LRIM1 and CTL4, were also silenced in An. stephensi (Nijmegen Sda500) females infected with P.
yoelii (17XNL). For five of the six genes tested, silencing had the same effect on infection in the P.
falciparum-An. gambiae and P. yoelii-An. stephensi parasite-vector combinations. Although silencing
LRIM1 or CTL4 has no effect in An. stephensi females infected with P. yoelii, when An. gambiae is
infected with the same parasite, silencing these genes has a dramatic effect. In An. gambiae (G3),
TEP1, LRIM1 or LRIM2 silencing reverts lysis and melanization of P. yoelii, while CTL4 silencing
enhances melanization.
Conclusion: There is a broad spectrum of compatibility, the extent to which the mosquito
immune system limits infection, between different Plasmodium strains and particular mosquito
strains that is mediated by TEP1/LRIM1 activation. The interactions between highly compatible
animal models of malaria, such as P. yoelii (17XNL)-An. stephensi (Nijmegen Sda500), is more similar
to that of P. falciparum (3D7)-An. gambiae (G3).
Background
Mosquitoes transmit many infectious diseases, including
malaria, lymphatic filariasis, yellow fever, and dengue.
Among these diseases, malaria is by far the most costly in
terms of human health. It is endemic to more than 100
countries and causes 550 million cases per year, with the
highest mortality in children from sub-Saharan Africa.
Malaria transmission to humans requires a competent
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mosquito species, as Plasmodium parasites must undergo a
complex developmental cycle and survive the defense
responses of their insect host. In Africa, Anopheles gambiae
is the major vector of Plasmodium falciparum infection,
which causes the most aggressive form of human malaria.
The Plasmodium berghei (murine malaria) model is one of
the most widely used experimental systems to study
malaria transmission. Gene silencing by systemic injec-
tion of double-stranded RNA (dsRNA) has proven to be a
very useful tool to carry out functional genomic screens
aimed at identifying mosquito genes that mediate anti-
parasitic responses. In general, Anopheles gambiae is con-
sidered to be susceptible to P. berghei infection, because a
high prevalence of infection can be achieved and parasites
are only rarely melanized; however, silencing of either
thioester-containing protein 1 (TEP1) [1], leucine-rich
repeat immune protein 1 (LRIM1) [2], or LRIM2 (also
called APL1, [3]), enhances P. berghei infection by 4–5
fold; indicating that, when these effector molecules are
present, about 80% of parasites are eliminated by a lytic
mechanism[1]. It is well documented that An. gambiae
mosquitoes have a different transcriptional response to
infection with P. berghei and P. falciparum [4,5] and genes
such as LRIM1 and C-type lectin 4 (CTL4) [2], which limit
or enhance P. berghei infection, respectively, do not affect
P. falciparum infection in An. gambiae [6]. This raises the
possibility that some antiplasmodial genes identified
using the P. berghei malaria model may not be relevant to
human malaria transmission.
More than 400 species of anopheline mosquitoes have
been identified, but only 40 of them are considered to be
important disease vectors [7]. Different anopheline spe-
cies and even particular strains of mosquitoes vary widely
in their susceptibility to infection with a given Plasmodium
parasite species. For example, twelve different strains of
Anopheles stephensi have been shown to have very different
susceptibility to P. falciparum (Welch strain) infection [8].
Furthermore, susceptibility had a strong genetic compo-
nent, which allowed selection of a An. stephensi strain
(Nijmegen Sda500) that is highly susceptible to P. falci-
parum infection [8]. A strain of An. gambiae (L35) was
selected to be highly refractory to infection with Plasmo-
dium cynomolgy (primate malaria). The L35 strain melan-
izes  P. cynomolgy, as well as several other Plasmodium
species such as P. berghei (murine malaria), Plasmodium
gallinaceum (avian malaria), and other primate malaria
parasites such as Plasmodium gonderi, Plasmodium inui, and
Plasmodium knowlesi. Interestingly, P. falciparum strains
from the New World are also melanized effectively, but
not those of African origin, suggesting that there are
genetic differences between P. falciparum strains that affect
their ability to infect An. gambiae [9]. The African strains
of P. falciparum tested appeared to be better adapted to
their natural mosquito vector. However, great differences
in the level of resistance to P. falciparum infection have
been documented in families derived from individual An.
gambiae females collected in the field [3,10], and a small
region of chromosome 2L is a major determinant of
genetic resistance to infection [3].
Drosophila melanogaster can support the development of
Plasmodium gallinaceum oocysts when cultured ookinetes
are injected into the hemocele [11]. This observation
opened the possibility of using a genetic approach to
screen for Drosophila genes that affect Plasmodium P. gall-
inaceum  infection[12]. Furthermore, silencing of
orthologs (or family members) of five of these candidate
genes in An. gambiae (G3 strain) demonstrated that four
of them also affected P. berghei infection in the mosquito
[12].
In this study we compare how silencing a set of genes
identified in the Drosophila  screen affects Plasmodium
infection in different vector-parasite combinations. We
conclude that there is a broad range of compatibility
between different Plasmodium strains and particular mos-
quito strains that is determined by the interaction
between the parasite and the mosquito's immune system.
We define compatibility as the extent to which the
immune system of the mosquito is actively limiting Plas-
modium infection. For example, the P. yoelii-An. stephensi
and P. falciparum-An. gambiae strains used in this study are
highly compatible vector-parasite combinations, as
silencing several genes involved in oxidative response or
immunity has no significant effect on infection. In con-
trast, silencing the same genes has a strong effect in less
compatible vector-parasite combinations such as P. yoelii-
An. gambiae or P. berghei-An. gambiae.
Results and discussion
Effect of GSTT1 and GSTT2 silencing on P. berghei 
infection
The effect of silencing An. gambiae orthologs (or
homologs) of genes originally identified in the Drosophila
genetic screen on P. berghei infectivity is summarized in
Table 1[12]. Knockdown of arginine kinase (ArgK) and
oxidation resistance gene 1 (OXR1) reduces infection. Tet-
raspanin and heat-shock cognate 3 (Hsc-3) silencing have
the opposite effect, enhancing infection, while reducing
the expression of the solute transporter (Sol. Trsp.) gene
did not affect infection with P. berghei [12]. The effect of
silencing two An. gambiae homologs of a glutathione S-
transferase of the theta class (GSTT) (CG1702-PA) gene
also identified in the Drosophila screen on P. berghei infec-
tion was evaluated. Injection of GSTT1  (AGAP000761-
PA) or GSTT2 (AGAP000888-PA) dsRNA reduced mRNA
expression by 60% and 55%, respectively, relative to the
control groups injected with dsLacZ. Both GSTT1  andBMC Microbiology 2009, 9:154 http://www.biomedcentral.com/1471-2180/9/154
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GSTT2 knockdown significantly reduce P. berghei infec-
tion (P < 0.05 and P < 0.03, respectively) using the Kol-
mogorov-Smirnov (KS) test (Figure 1 and Table 1).
Direct comparison of the effect of silencing seven An. 
gambiae genes on P. berghei and P. falciparum infection
The effect of reducing expression of the five genes previ-
ously reported [12] as well as GSTT1 and GSTT2 in An.
gambiae infected with P. falciparum (3D7 strain) was eval-
uated (Figure 2). Silencing of ArgK and Hsc-3 significantly
reduced infection (P < 0.05 and P < 0.001, respectively,
using the KS test) (Figure 2A, B). Sol. Trsp., GSTT1, and
OXR1 silencing did not affect P. falciparum infection (Fig-
ure 2C–E), while tetraspanin and GSTT2  knockdown
enhanced infection (P < 0.01 and P < 0.03; KS test) (Figure
2F, G). A summary of these results is shown in Table 1.
Silencing ArgK, Sol. Trsp., and tetraspanin genes has a sim-
ilar effect on P. berghei and P. falciparum infection. ArgK is
a key enzyme in cellular energy homeostasis in arthro-
pods, with a function similar to that of creatine kinase in
mammals. This enzyme catalyzes the synthesis of phos-
phoarginine, which serves as an energy reserve. The high-
energy phosphate in phosphoarginine can be transferred
to ADP to renew ATP during periods of high energy
demand [13]. Apparently, silencing this enzyme results in
a physiologic state in the mosquito that does not foster
the development of either P. berghei or  P. falciparum.
Silencing of the solute transporter has no effect, while
knockdown of tetraspanin enhances infection with both
parasites. Tetraspanins are proteins with four transmem-
brane (TM) domains that are associated extensively with
one another and with other membrane proteins to form
specific microdomains distinct from lipid rafts. They are
expressed on the surface of numerous cell types and are
involved in diverse processes from cell adhesion to signal
transduction and some of them inhibit the function of
other members of the same family of proteins [14]. CD81
is a tetraspanin that has been shown to be required for
hepatocyte invasion by P. falciparum and P. yoelii sporo-
zoites [15]. Silencing of the An. gambiae tetraspanin gene
may enhance parasite invasion and/or prevent the activa-
tion of an immune cascade that limits infection with P.
berghei and P. falciparum.
OXR1, GSTT1, GSTT2 and Hsc-3 silencing has a different
effect on P. berghei and P. falciparum infection. In yeast
and mammals, OXR1 is induced by heat and oxidative
stress and prevents oxidative damage by an unknown
mechanism [16]. In An. gambiae,  OXR1  silencing
decreases resistance to oxidative challenge and prevents
the induction of genes involved in ROS detoxification,
such as catalase, following a blood meal (G. Jaramillo-
Gutierrez and C. Barillas-Mury, unpublished). We have
previously shown that higher ROS levels in An. gambiae
reduce P. berghei infection [17]. Thus, it is likely that the
decrease in P. berghei infectivity following OXR1 silencing
is due to an increase in ROS. The unexpected observation
that OXR1 silencing does not affect P. falciparum infection
suggests that either this parasite species is less susceptible
to oxidative stress or that the ingestion of human blood
results in less accumulation of ROS in the mosquito.
GSTs play an important role as antioxidants and are
involved in the detoxification of xenobiotics. GSTs of the
epsilon and delta class have been extensively studied for
their role in insecticide resistance in mosquitoes [18]. The
GST-Theta1 (GSTT1) null genotype in human males is
highly associated to increased risk of basal cell carcinoma
of the skin [19]. Furthermore, in diabetics, the deletion of
one copy of the GSTT1 gene is associated with elevated
markers of inflammation and lipid peroxidation [20].
Therefore, silencing of GSTT1 and GSTT2 could result in
increased lipid peroxidation, which is expected to be del-
eterious to P. berghei; however, it is not clear why reducing
GSTT2 expression enhances P. falciparum infection.
Susceptibility of An. stephensi (Nijmegen Sda500 strain) 
and An. gambiae (G3) to P. yoelii infection
The observed differences in the effect of silencing specific
An. gambiae (G3 strain) genes on P. berghei and P. falci-
Effect of silencing An. gambiae (G3) GSTT1 and GSTT2 on P.  berghei infection Figure 1
Effect of silencing An. gambiae (G3) GSTT1 and GSTT2 
on P. berghei infection. Panel A, Effect of silencing glutath-
ione-S-transferase theta-1 (GSTT1) on Plasmodium infection. 
GFP-expressing parasites were counted directly 6 days post 
infection (PI). Panel B, Effect of silencing glutathione-S-trans-
ferase theta-2 (GSTT2) on Plasmodium infection. Infection 
levels were determined based on the relative abundance of P. 
berghei 28S and An. gambiae S7 genes in genomic DNA iso-
lated from midguts 6 days PI. The dots represent the infec-
tion level on individual midguts, and the median infection 
level is indicated by the horizontal line. Distributions are 
shown using a logarithmic scale for GSTT2 and are compared 
using the Kolmogorov-Smirnov (KS) test; n = number of 
mosquitoes; P values lower than 0.05 are considered to be 
significantly different.BMC Microbiology 2009, 9:154 http://www.biomedcentral.com/1471-2180/9/154
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parum infection may reflect the degree of compatibility
between these two parasite species and the mosquito
strain used. Alternatively, mosquitoes may trigger differ-
ent sets of effector genes in response to different Plasmo-
dium species. To explore these possibilities, we evaluated
the responses of two mosquito species that differ in their
susceptibility to the same Plasmodium parasite.
The susceptibility of An. stephensi (Nijmegen Sda500), a
strain highly susceptible to P. falciparum infection [8], and
An. gambiae (G3) females to P. yoelii infection was com-
pared by feeding them on the same infected mouse. An.
stephensi is highly susceptible to P. yoelii infection, as no
melanized parasites are observed and the median number
of live oocysts is 51-fold higher than in An. gambiae (Fig-
ure 3A, C and Table 2). In contrast, An. gambiae (G3) is
partially refractory and has two distinct phenotypes (Fig-
ure 3B). In approximately half of the mosquitoes, all par-
asites are melanized, while in the other half, parasite lysis
appears to be the main defense response, as no melaniza-
tions are observed (Figure 3C, D). Interestingly, the prev-
alence of mixed phenotypes–that is, mosquitoes in which
both live and melanized parasites are observed–is low
(10%; Table 2). These results are in agreement with a pre-
vious report in which susceptibility of An. gambiae (G3)
and An. stephensi (Pakistan) to P. yoelii infection was com-
pared [21].
Effect of silencing An. stephensi orthologs on P. yoelii 
infection
Six genes whose phenotypes differ when An. gambiae is
infected with P. berghei or P. falciparum were examined.
An. stephensi orthologs of OXR1,  Hsc-3,  GSTT1, and
GSTT2, as well as two other genes previously reported in
the literature (LRIM1 and CTL4), were silenced, and the
effect on P. yoelii infection was evaluated. Five of the six
genes tested had similar effects in the An. gambiae-P. falci-
parum and the An. stephensi-P. yoelii systems (Table 1).
Silencing OXR1, LRIM1, CTL4, or GSTT1 had no effect,
while GSTT2 and Hsc-3 silencing enhanced P. yoelii infec-
tion in An. stephensi (Figure 4 and Table 1). Hsc-3 was the
only gene that gave a different phenotype between An.
gambiae-P. falciparum and  An. stephensi-P. yoelii. Con-
versely, this was also the only gene that had a similar phe-
notype in An. gambiae infected with P. berghei and in P.
yoelii-infected An. stephensi. The expression of heat shock
proteins is temperature dependent; thus the differences in
the effect of Hsc-3 silencing in mosquitoes infected with
different Plasmodium species could be due to physiologic
differences resulting from the temperature at which
infected mosquitoes are kept. For example, Hsc-3 silenc-
ing decreases P. falciparum infection (26°C) in An. gam-
biae but results in a significant but mild increase in P. yoelii
infection (24°C) in An. stephensi and a strong enhance-
ment of P. berghei infection (21°C) in An. gambiae. Inter-
estingly, a decrease in parasite number is also observed in
the Drosophila line in which a P-element has been inserted
close to the Hsc-3 gene. In the fly system, in vitro cultured
P. gallinaceum ookinetes are injected into the hemocele
and the infected flies kept at 27°C [12]. It appears that
silencing Hsc-3 decreases Plasmodium infection when the
infected insects are kept at a higher temperature but has
the opposite effect, enhancing infection, when infected
insects are kept at a lower temperature.
Refractoriness of An. gambiae (G3) to P. yoelii infection 
is due to activation of the mosquito immune system
The fact that LRIM1 and CTL4 silencing in An. stephensi
(Nijmegen Sda500 strain) had no effect on P. yoelii infec-
tion could reflect a lack of activation of the immune sys-
tem in this highly susceptible mosquito strain.
Alternatively, it is also possible that LRIM1 and CTL4 do
not participate in mosquito antiparasitic responses to P.
yoelii. To explore these two possibilities, the effect of CTL4
and LRIM1 silencing in An. gambiae (G3) females, which
are partially refractory to P. yoelii infection, was investi-
Table 1: Effect of silencing seven An. gambiae genes or their orthologs in An. stephensi on the intensity of P. berghei, P. falciparum or P. 
yoelii infection.
An. gambiae Gene ID Gene An. gambiae P. berghei (21°C) An. gambiae P. falciparum (26°C) An. stephensi P. yoelii (24°C)
AGAP005627 ArgK Decrease1 Decrease
AGAP010892 Sol. trsp. No effect1 No effect
AGAP005233 Tetrasp. Increase1 Increase
AGAP001751 OXR1 Decrease1 No effect No effect
AGAP004192 Hsc-3 Increase1 Decrease Increase
AGAP000761 GSTT1 Decrease No effect No effect
AGAP000888 GSTT2 Decrease Increase Increase
AGAP006348 LRIM1 Increase2 No effect.3 No effect
AGAP005335 CTL4 Decrease2 No effect.3 No effect
1Brandt et al., 2008
2Osta et al., 2004
3Cohuet et al., 2006BMC Microbiology 2009, 9:154 http://www.biomedcentral.com/1471-2180/9/154
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gated. CTL4 silencing increases the number of melanized
parasites from 62% to 95% (Figure 3A). Conversely,
LRIM1 silencing completely reverts P. yoelii melanization
and increases the median number of live oocysts by 4.6
fold (Figure 5B). To further investigate the participation of
the An. gambiae immune system on the partial refractori-
ness of this species to P. yoelii infection, the effect of silenc-
ing TEP1 and LRIM2 was also evaluated. TEP1 and LRIM2
had a similar effect as LRIM1, enhancing infection by 32
and 20.5 fold, respectively (Figure 5C, D).
Conclusion
The effect of silencing multiple mosquito genes in the
highly compatible P. yoelii (17XNL)-An. stephensi
(Nijmegen Sda500)system was very similar to that
observed when P. falciparum (3D7) was used to infect An.
gambiae (G3), its natural vector; suggesting that P. yoelii-
An. stephensi is a representative animal model to study P.
falciparum interactions with compatible vectors. Further-
more, P. yoelii-infected females can be kept at 24°C, a tem-
perature that is more physiological for mosquitoes and
closer to that used for P. falciparum infections (26°C).
Using less compatible parasite-mosquito combinations,
such as the P. berghei-An. gambiae or P. yoelii-An. gambiae
strains described in this study, may be particularly useful
to identify and characterize immune pathways in the mos-
quito that could potentially limit human malaria trans-
mission. Once a potential pathway is defined, it is
possible to investigate if certain parasite strains avoid acti-
Effect of silencing several An. gambiae (G3) genes on parasite P. falciparum infection Figure 2
Effect of silencing several An. gambiae (G3) genes on parasite P. falciparum infection. Effect of silencing arginine 
kinase (ArgK) (Panel A), heat shock cognate 3 (Hsc-3) (Panel B), solute transporter (Sol. Trsp.) (Panel C), glutathione-S-trans-
ferase theta-1 (GSTT1) (Panel D), oxidation resistance gene 1 (OXR1) (Panel E) tetraspanin (Tetrasp.) (Panel F), and glutathione-
S-transferase theta-2 (GSTT2) (Panel G) on P. falciparum infection. The number of P. falciparum oocysts present was determined 
by directly counting mercurochrome-stained parasites 7–8 days post infection. The dots represent the number of parasites 
present on individual midguts, and the median number of oocysts is indicated by the horizontal line. Distributions are com-
pared using the Kolmogorov-Smirnov test; n = number of mosquitoes; P values lower than 0.05 are considered to be signifi-
cantly different.BMC Microbiology 2009, 9:154 http://www.biomedcentral.com/1471-2180/9/154
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vating them, or if the effector genes are inefficient. It may
also be possible to use alternative strategies (such as
chemicals or fungal infections) to activate these potential
antiplasmodial responses and test their effectiveness in
limiting malaria transmission in natural vector-parasite
combinations.
There is a broad spectrum of compatibility between differ-
ent strains of Plasmodium and particular mosquito strains;
for example, An. gambiae (G3) is highly compatible with
P. falciparum (3D7) parasites, but has low compatibility
with P. yoelii 17XNL. A given strain of Plasmodium can also
be more compatible with certain mosquitoes. For exam-
ple, P. yoelii 17XNL is much more compatible with An.
stephensi (Nijmegen Sda500 strain) than with An. gambiae
(G3). TEP1 silencing in An. gambiae (Keele strain) mos-
quitoes enhances infection with P. falciparum (NK54
strain), doubling the median number of oocysts [22].
Silencing TEP1 in An. gambiae has a more dramatic effect
(4–5 fold increase) on P. berghei infection [1]. Further-
more, silencing TEP1 in An. gambiae (G3 strain) does not
enhance infection with P. falciparum (NF54 strain), indi-
cating that there are differences in compatibility between
particular strains of An. gambiae and P. falciparum (M. Pov-
elones and A. Molina-Cruz, unpublished).
Over activation of the Rel2 pathway by silencing Caspar, a
critical suppressor of this cascade, drastically reduces P.
falciparum (NK54 strain) infection in An. gambiae (Keele
strain), An. albimanus (Santa Tecla strain) and An. stephensi
mosquitoes [22]. Double silencing experiments in An.
gambiae (Keele strain) females, in which Caspar and TEP1
(or other effectors of the Rel2 pathway) were co-silenced,
rescues the effect of Caspar, indicating that TEP1  is an
important effector of this response. The fact that strong
activation of the Rel2 pathway can very effectively prevent
infection in several mosquito species that are natural vec-
tors of P. falciparum [22], begs the question of why this
immune response is not effective preventing disease trans-
mission under natural field conditions.
Susceptibility of An. stephensi (Nijmegen Sda500) and An. gam- biae (G3) to P. yoelii infection Figure 3
Susceptibility of An. stephensi (Nijmegen Sda500) and 
An. gambiae (G3) to P. yoelii infection. An. stephensi and 
An. gambiae mosquitoes were fed on the same P. yoelii-
infected mouse. The images illustrate the level of infection 
and parasite melanization observed 6 days post infection (PI) 
in An. stephensi (Panel A) or An. gambiae (Panel B) females 
infected with P. yoelii. Live parasites are detected with green 
fluorescence (left panels), and those melanized are in DIC 
images (right panels). Panel C, Number of live (green dots) 
or melanized (black dots) parasites present on individual mid-
guts 6 days PI. The median number of oocysts is indicated by 
the horizontal line. Distributions are compared using the 
Kolmogorov-Smirnov test; n = number of mosquitoes; P val-
ues lower than 0.05 are consider to be significantly different. 
Panel D, The number of live (green dots) and melanized 
(black dots) P. yoelii parasites on individual An. gambiae mid-
guts is shown connected by a line. In most mosquitoes, either 
all parasites are alive or all are melanized. There are very few 
midguts in which both live and melanized parasites are 
observed.
Table 2: An. gambiae (G3) and An. stephensi (Nijmegen Sda500) infections with P. yoelii.
Mosquito species Prevalence of 
infection
Median live oocyst 
number
Oocyst range % of midguts with 
melanized parasites
% of midguts with live 
and melanized 
parasites
An. gambiae
n = 59
52% 1 0–65 59% 10%
An. stephensi
n = 47
100% 51 2–302 0% 0%BMC Microbiology 2009, 9:154 http://www.biomedcentral.com/1471-2180/9/154
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It has been proposed that P. falciparum parasites have
evolved specific mechanisms to modulate activation of
the An. gambiae immune system as they adapted to their
natural mosquito vector [23,24]. The observation that P.
falciparum strains from the New World, such as the Brazil-
ian P. falciparum 7G8 strain, are melanized very effectively
by the An. gambiae L35 strain but not those of African ori-
gin [9] adds support to the adaptation hypothesis. Recent
experiments revealed that LRIM1  can also mediate
immune responses against P. falciparum, because silencing
Effect of silencing several An. stephensi (Nijmegen Sda500) genes on P. yoelii infection Figure 4
Effect of silencing several An. stephensi (Nijmegen Sda500) genes on P. yoelii infection. Effect of silencing heat shock 
cognate 3 (Hsc-3) (Panel A), oxidation resistance gene (OXR1) (Panel B), glutathione-S-transferase theta-1 (GSTT1) (Panel C), 
glutathione-S-transferase theta-2 (GSTT2) (Panel D), leucine rich-repeat immune protein 1 (LRIM1) (Panel E), and C-type lectin 
4 (CTL4) (Panel F) on P. yoelii infection. The dots represent the number of oocysts present on individual midguts 6 days post 
infection. The median number of oocysts is indicated by the horizontal line. Distributions are compared using the Kolmogorov-
Smirnov test; n = number of mosquitoes; P values lower than 0.05 are consider to be significantly different.BMC Microbiology 2009, 9:154 http://www.biomedcentral.com/1471-2180/9/154
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this gene in An. gambiae L35 females infected with the Bra-
zilian P. falciparum 7G8 strain completely reverts the mel-
anization phenotype and results in live oocysts (A.
Molina-Cruz, A and C. Barillas-Mury, unpublished).
Selection for refractoriness to P. cynomolgy resulted in a
strain of An. gambiae that is also refractory to multiple
Plasmodium species. LRIM1 also mediates the antiparasitic
responses of Anopheles quadriannulatus to P. berghei infec-
tion [25]. These findings indicate that some genes, such as
TEP1/LRIM1, are broad mediators of antiparasitic
responses against several different Plasmodium parasites in
different mosquito strains.
Under natural conditions, P. falciparum parasites must
avoid or withstand the antiparasitic responses of An. gam-
biae to complete their life cycle and this is likely to exert
selective pressure on parasite populations. For example, in
Southern Mexico, three genetically distinct P. vivax popu-
lations have been identified, and experimental infections
indicate that parasites are most compatible with sympatric
mosquito species [26]. The authors propose that recipro-
cal selection between malaria parasites and mosquito vec-
tors has led to local adaptation of parasites to their vectors
[26]. Thus, it is likely that in well-adapted systems there is
some level of immune evasion and/or suppression, and
this could explain why silencing some genes involved in
immunity (LRIM1, CTL4) or oxidative stress (OXR1,
GSTT1 and GSTT2) in An. gambiae (G3) females, has little
effect on P. falciparum (3D7 strain) infection.
There is also increasing evidence from many different
studies that the interaction between Plasmodium parasites
and the mosquito immune system it is a strong determi-
nant of vectorial capacity. Nevertheless, the extent to
which the mosquito immune system is effectively reduc-
ing Plasmodium infection is very variable, even between
particular parasite and mosquito strains. These differences
in compatibility need to be evaluated and carefully con-
sidered when selecting an experimental animal model to
study malaria transmission.
Methods
Mosquito rearing
An. gambiae (G3 strain) and An. stephensi (Nijmegen
Sda500) mosquitoes were raised at 28°C, 75% humidity
under a 12-hour light/dark cycle and maintained on a
10% sucrose solution during adult stages.
P. berghei and P. yoelii yoelii GFP 17XNL infections
Either wild-type or GFP-P. berghei (ANKA 2.34 strain) [27]
and the GFP-P. yoelii yoelii 17X nonlethal transgenic strain
[28] were maintained by serial passage in 3- to 4-week-old
female BALB/c mice or as frozen stocks. Mice parasitemias
were monitored by light microscopy using air-dried blood
smears that were methanol fixed and stained with 10%
Giemsa. Female mosquitoes (4–5 days old) were fed on
gametocytemic mice 2–3 days after blood inoculation
from infected donor mice when parasitemias were
between 5–10%. Mosquitoes infected with P. berghei or P.
yoelii were kept at 21°C or 24°C, respectively, and mid-
guts dissected 6–7 days post infection. Infection levels
were determined by fluorescent (live oocyst) and light
(melanized parasites) microscopy. The distribution of
oocyst numbers in the different experimental groups was
Effect of silencing An. gambiae (G3) CTL4, LRIM1, TEP1, or  LRIM2 on P. yoelii infection Figure 5
Effect of silencing An. gambiae (G3) CTL4, LRIM1, 
TEP1, or LRIM2 on P. yoelii infection. The images illus-
trate the level of infection and parasite melanization 
observed 6 days post infection (PI) when each gene was 
silenced. Live parasites are detected with green fluorescence 
(left panels) and those melanized are in DIC images (right 
panels). Effect of silencing C-type lectin 4 (CTL4) (Panel A), 
leucine rich-repeat immune protein 1 (LRIM1) (Panel B), 
thioester-containing protein 1 (TEP1) (Panel C), or leucine 
rich-repeat immune protein 2 (LRIM2) (Panel D) on P. yoelii 
infection. The dots represent the number of live (green) or 
melanized (black) parasites on individual midguts 6 days PI. 
The median number of oocysts is indicated by the horizontal 
line. Distributions are compared using the Kolmogorov-
Smirnov test; n = number of mosquitoes; P values lower than 
0.05 are consider to be significantly different.BMC Microbiology 2009, 9:154 http://www.biomedcentral.com/1471-2180/9/154
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compared using the nonparametric Kolmogorov-Smirnov
statistical test.
Mosquito midgut genomic DNA extraction for 
quantitative real-time PCR (qPCR)
Individual midguts (without blood) were placed into
microcentrifuge tubes containing 10 μl of HotSHOT alka-
line lysis reagent (25 mM NaOH, 0.2 mM EDTA, pH 12.0)
[29]. The tubes were boiled for 5 min and immediately
placed on ice; 10 μl of HotSHOT neutralizing reagent (40
mM Tris-HCl, pH 5.0) was added to each tube. The sam-
ples were centrifuged and stored at -20°C.
Determination of P. berghei infection by qPCR
For the GSTT1 silencing experiment, mice were infected
wild-type P. berghei (non-GFP parasites, Anka 2.34 para-
sites), and the level of infection in mosquitoes was deter-
mined by qPCR 6 days post infection. Genomic DNA was
obtained from infected midguts, and the abundance of P.
berghei 28S RNA relative to An. gambiae S7 ribosomal pro-
tein was determined. The DyNAmo SYBR Green qPCR
Master mix (Finnzymes, Espoo, Finland) was used to
amplify the genomic DNA, and samples were run on a MJ
Research Detection system according to the manufac-
turer's instructions (Bio-Rad, Hercules, CA). P. berghei 28S
RNA primer sequence (5/ to 3/), Fw-GTGGCCTATC-
GATCCTTTA and Rev: 5/GCGTCCCAATGA TAGGAAGA).
Two μl of midgut genomic DNA was used to detect the
number P. berghei 28S gene copies and 1 μl to determine
the copies of An. gambiae ribosomal protein S7 gene in a
20-μl PCR reaction. All P. berghei 28S values shown were
then normalized relative to the number of copies of S7 in
the sample. The distribution of parasite/midgut genome
in control (dsLacZ injected) and dsGSTT2 silenced were
compared using the Kolmogorov-Smirnov test.
Experimental infection of An. gambiae mosquitoes with 
P. falciparum
An. gambiae (G3) female mosquitoes were infected with P.
falciparum by feeding them gametocyte cultures using an
artificial membrane feeding system. The P. falciparum
(3D7 strain) was maintained in O+ human erythrocytes
using RPMI 1640 medium supplemented with 25 mM
HEPES, 50 mg/L hypoxanthine, 25 mM NaHCO3, and
10%(v/v) heat-inactivated type O+ human serum [30,31].
Gametocytogenesis was induced following the procedure
of Ifediba and Vanderberg [32]. Mature gametocyte cul-
tures (stages IV and V) that were 14–16 days old were used
to feed mosquitoes in 37°C warmed membrane feeders
for 30 minutes. To determine the level of infection, the
midguts were dissected and stained with 0.05% (w/v)
mercurochrome in water and oocysts counted by light
microscopy 7–9 days post blood feeding. Distribution of
oocyst numbers per midgut was analyzed using the Kol-
mogorov-Smirnov test.
dsRNA synthesis
cDNA fragments of 500–600 bp were amplified for each
gene using the primers shown in Additional File 1 and
cDNA from 4-day-old An. gambiae females as template.
The cDNA fragments were cloned into the pCR II-TOPO®
vector (Invitrogen, Carlsbad, CA) and T7 sites introduced
at both ends using the following vector primers (5' to 3')
to amplify the cDNA insert; M13-Fw: GTAAAACGACG-
GCCAGT and T7-M13Rev: CTCGAGTAATACGACT-
CACTA TAGGGCAGGAAACAGCTATGAC. dsRNA was
synthesized and purified using the MEGAscript kit
(Ambion, Austin, TX). The eluted dsRNA was further
cleaned and concentrated to 3 μg/μl using a Microcon YM-
100 filter (Millipore, Bedford, MA).
Silencing An. gambiae genes
dsRNA (207 ng in 69 nl) for each of the genes tested was
injected into the thorax of cold-anesthetized 1- to 2-day-
old female mosquitoes using a nano-injector (Nanoject;
Drummond Scientific, Broomall, PA). In each experi-
ment, a control group was injected with dsLacZ or dsGFP
to serve as reference for intensity of infection. Gene silenc-
ing was confirmed 4 days after dsRNA injection by RT-
qPCR using the ribosomal S7 gene for normalization.
Poly(A) mRNA was isolated from groups of 10 adult
females using Oligotex-dT beads (Qiagen, Valencia, CA)
following the manufacturer's instructions. First-strand
cDNA was synthesized using random hexamers and
Superscript II reverse transcriptase (Invitrogen). The prim-
ers used for each gene are shown in Additional File 2.
Gene expression was assessed by SYBR green qPCR
(DyNAmo HS; New England Biolabs, Beverly, MA) in a
Chromo4 system (Bio-Rad). PCR involved an initial dena-
turation at 95°C for 15 minutes, 44 cycles of 10 seconds
at 94°C, 20 seconds at 58°C, and 30 seconds at 72°C. Flu-
orescence readings were taken at 72°C after each cycle. A
final extension at 72°C for 5 minutes was completed
before deriving a melting curve (70°C–95°C) to confirm
the identity of the PCR product. qPCR measurements
were made in duplicate.
Silencing An. stephensi genes
Because all the genes tested are highly conserved across
species, we tested whether it was possible to silence An.
stephensi genes by injecting them with dsRNA from orthol-
ogous genes of An. gambiae. An. stephensi female mosqui-
toes (1–2 days old) were injected with dsRNA from An.
gambiae cDNAs following the same procedure described
above. Silencing efficiency was determined using qPCR 4
days after mosquitoes were injected with dsRNA. For the
initial evaluation, the same primers and conditions as for
An. gambiae were used, except for a lower annealing tem-
perature (52°C instead of 58°C). For OXR1, a strong peak
was obtained using the same primers as for An. gambiae,
but for all other genes, several primer combinations fromBMC Microbiology 2009, 9:154 http://www.biomedcentral.com/1471-2180/9/154
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well conserved regions had to be designed to obtain effi-
cient amplification that generated a single band of the
expected molecular weight. For GSTT1, in was necessary
to clone a fragment of An stephensi cDNA using the follow-
ing degenerate primers (5/ to 3/), Fwd: CTGGCGGAAAGT
GTKGCCAT and Rev: GGCCGCAGCCASACGTACT-
GGAA. A 180-bp fragment was amplified, sequenced, and
used to generate a primer combination that would effi-
ciently amplify AsGSTT1. Sequences of all primer sets
used for qRT-PCR analysis with An. stephensi templates are
shown in Additional File 3. Silencing efficiency in An.
gambiae  and An. stephensi, shown in Additional File 4,
ranged from 55–98% and from 56–84%, respectively.
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